Simpler Grants.gov #PAR-25-337

NIH Grant for Academic-Industrial Partnerships in Translational Technologies for Diagnosis and Treatment

This opportunity from the National Cancer Institute (NCI) at the National Institutes of Health (NIH) seeks to fund academic-industrial partnerships for translational technologies in disease diagnosis and treatment. - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI) - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a research grant solicitation - Products/Services Requested: - Research and development projects translating scientific and engineering advances into technologies and methods for disease diagnosis and treatment - Focus on cancer detection and treatment, with relevance to pre-clinical, clinical, and non-clinical settings - No specific part numbers or product quantities; emphasis is on innovative research outcomes - Unique or Notable Requirements: - Projects must align with the missions of participating NIH institutes - Open to a wide range of applicants, including government agencies, nonprofits, educational institutions, businesses, and foreign entities - Minimum award amount is $499,000 - No cost sharing or matching requirement - Both domestic and international projects are eligible - Funding Instrument: - Discretionary grant under Assistance Listings 93.395 and 93.394 - Place of Performance: - National Institutes of Health (NIH)

Description

The National Cancer Institute (NCI) seeks to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic and applied research related to disease understanding, risk assessment, detection, prevention, diagnosis, treatment, and management. The goal is to deliver new capabilities for technologies and methods relevant to research and care delivery in pre-clinical, clinical, and non-clinical settings, both domestic and foreign. This funding opportunity supports projects within the missions of participating institutes, focusing on cancer treatment and detection research.

View original listing